Trials / Unknown
UnknownNCT03116217
Validation of a Fetal Urine Peptidome-based Classifier to Predict Post-natal Renal Function in Posterior Urethral Valves
Multicentre Validation of a Fetal Urine Peptidome-based Classifier to Predict Post-natal Renal Function in Posterior Urethral Valves
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 400 (estimated)
- Sponsor
- University Hospital, Toulouse · Academic / Other
- Sex
- Female
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
Validate the use of fetal urine peptidome-analysis and explore amniotic fluid markers for the stratification of fetuses with Posterior Urethral Valve for post-natal renal function.
Detailed description
The ANTENATAL project requires the use of fetal urine as well as post-natal urine, post-natal serum and, possibly, amniotic liquid. We will take an additional tube during the takings collected for routine management of the disease. The analysis of samples will be carried out in Toulouse at the Institute of Metabolic and Cardiovascular Diseases or with fee-for-service suppliers.
Conditions
Timeline
- Start date
- 2017-06-26
- Primary completion
- 2023-12-26
- Completion
- 2023-12-26
- First posted
- 2017-04-17
- Last updated
- 2023-08-23
Locations
29 sites across 9 countries: Belgium, France, Germany, Italy, Netherlands, Poland, Spain, Switzerland, United Kingdom
Source: ClinicalTrials.gov record NCT03116217. Inclusion in this directory is not an endorsement.